Nitric Oxide, Other

In addition, although the current presence of nucleocapsid-specific antibodies is recognized as the typical marker for earlier infection generally, we find that antibody waning is in a way that up to 50% of individuals will eventually lose detectable antibody responses within 8 weeks; therefore estimates from the proportion from the LTCF human population with previous disease predicated on antibody tests will tend to be falsely low

In addition, although the current presence of nucleocapsid-specific antibodies is recognized as the typical marker for earlier infection generally, we find that antibody waning is in...